Document:

<PAGE>

                                                                    EXHIBIT 10.8

--------------------------------------------------------------------------------

                      ADAMS RESPIRATORY THERAPEUTICS, INC.

                           DIRECTOR COMPENSATION PLAN

--------------------------------------------------------------------------------

<PAGE>

                      ADAMS RESPIRATORY THERAPEUTICS, INC.
                           DIRECTOR COMPENSATION PLAN

                                TABLE OF CONTENTS

<TABLE>
<S>                                                                            <C>
ARTICLE 1 PURPOSE...........................................................   1

     1.1  Purpose...........................................................   1

     1.2  Eligibility.......................................................   1

ARTICLE 2 DEFINITIONS.......................................................   1

     2.1  Definitions.......................................................   1

ARTICLE 3 ADMINISTRATION....................................................   3

     3.1  Administration....................................................   3

     3.2  Reliance..........................................................   3

ARTICLE 4 SHARES............................................................   3

     4.1  Source of Shares for the Plan.....................................   3

ARTICLE 5 CASH COMPENSATION.................................................   4

     5.1  Base Annual Cash Retainer.........................................   4

     5.2  Supplemental Annual Cash Retainer.................................   4

     5.3  Meeting Fees......................................................   5

     5.4  Travel Expense Reimbursement......................................   5

ARTICLE 6 EQUITY COMPENSATION...............................................   5

     6.1  Annual Stock Retainer.............................................   5

     6.2  Stock Options.....................................................   7

ARTICLE 7 AMENDMENT, MODIFICATION AND TERMINATION...........................   8

     7.1  Amendment, Modification and Termination...........................   8

ARTICLE 8 GENERAL PROVISIONS................................................   9

     8.1  Adjustments.......................................................   9

     8.2  Duration of the Plan..............................................   9

     8.3  Expenses of the Plan..............................................   9

     8.4  Status of the Plan................................................   9

     8.6  Effective Date....................................................   9
</TABLE>

<PAGE>

                      ADAMS RESPIRATORY THERAPEUTICS, INC.
                           DIRECTOR COMPENSATION PLAN

                                    ARTICLE 1
                                     PURPOSE

         1.1. Purpose. The purpose of the Plan is to attract, retain and
compensate highly-qualified individuals who are not employees of Adams
Respiratory Therapeutics, Inc. or any of its subsidiaries or affiliates for
service as members of the Board by providing them with competitive compensation
and an ownership interest in the Stock of the Company. The Company intends that
the Plan will benefit the Company and its shareholders by allowing Non-Employee
Directors to have a personal financial stake in the Company through an ownership
interest in the Stock and will closely associate the interests of Non-Employee
Directors with that of the Company's shareholders.

         1.2. ELIGIBILITY. Non-Employee Directors of the Company who are
Eligible Participants, as defined below, shall automatically be participants in
the Plan.

                                    ARTICLE 2
                                   DEFINITIONS

         2.1.DEFINITIONS. Unless the context clearly indicates otherwise, the
following terms shall have the following meanings:

         (a) Base Annual Cash Retainer" means the annual cash retainer
(excluding meeting fees and expenses) payable by the Company to a Non-Employee
Director pursuant to Section 5.1 hereof for service as a director of the Company
(i.e., excluding any Supplemental Annual Cash Retainer), as such amount may be
changed from time to time.

         (b) "Board" means the Board of Directors of the Company.

         (c)"Cause" shall mean any of the following acts by the participant, as
determined by the Board: gross neglect of duty, fraud, prolonged absence from
duty without the consent of the Company, intentionally engaging in any activity
that is in conflict with or adverse to the business or other interests of the
Company, or willful misconduct, misfeasance or malfeasance of duty which is
reasonably determined to be detrimental to the Company.

         (d)"Company" means Adams Respiratory Therapeutics, Inc., a Delaware
corporation.

         (e)"Deferred Stock Unit" means a Restricted Stock Unit that has vested
in accordance with Section 6.1(b) of the Plan and represents the right to
receive one share of

<PAGE>

Stock at a designated future date, as provided in Section 6.1(c) of the Plan.

         (f)"Disability" has the meaning assigned such term in Section 409A of
the Internal Revenue Code of 1986, as amended. Subject to amendments to Code
Section 409A after the Effective Date, a participant shall be considered
Disabled if the participant (i) is unable to engage in any substantial gainful
activity by reason of any medically determinable physical or mental impairment
which can be expected to result in death or can be expected to last for a
continuous period of not less than 12 months, or (ii) is, by reason of any
medically determinable physical or mental impairment which can be expected to
result in death or can be expected to last for a continuous period of not less
than 12 months, receiving income replacement benefits for a period of not less
than three months under an accident and health plan covering employees of the
participant's employer.

         (g) "Effective Date" of the Plan means the date on which the final
(pricing) prospectus relating to the initial public offering of the Company's
Common stock is filed with the Securities Exchange Commission.

         (h) "Eligible Participant" means any person who is a Non-Employee
Director on the Effective Date or becomes a Non-Employee Director while this
Plan is in effect; except that during any period a director is prohibited from
participating in the Plan by his or her employer or otherwise waives
participation in the Plan, such director shall not be an Eligible Participant.

         (i) "Equity Incentive Plan" means the Adams Respiratory Therapeutics,
Inc. 2005 Incentive Plan, or any subsequent equity compensation plan approved by
the Board and designated as the Equity Incentive Plan for purposes of this Plan.

         (j) "Fair Market Value", on any date, has the meaning assigned such
term in the Equity Incentive Plan.

         (k) "Non-Employee Director" means a director of the Company who is not
an employee of the Company or any of its subsidiaries.

         (l) "Option" means a right to purchase Stock at a specified price
during specified time periods. Options granted under the Plan are non-statutory
stock options.

         (m) "Plan" means the Adams Respiratory Therapeutics, Inc. Director
Compensation Plan, as amended from time to time.

         (n) "Plan Year(s)" means the approximate twelve-month periods between
annual meetings of the shareholders of the Company, which, for purposes of the
Plan, are the periods for which annual retainers are earned.

                                      -2-
<PAGE>

         (o) "Restricted Stock Unit" means the right to receive one share of
Stock at a designated future date and after the applicable restrictions have
expired. The terms of Restricted Stock Units granted under the Plan are
described in Article 6 of the Plan.

         (p) "Stock" means the common stock, par value $.01 per share, of the
Company.

         (q) "Supplemental Annual Cash Retainer" means the annual cash retainer
(excluding meeting fees and expenses) payable by the Company to a Non-Employee
Director pursuant to Section 5.2 hereof for service as a chair of a committee of
the Board, as such amount may be changed from time to time.

                                    ARTICLE 3
                                 ADMINISTRATION

         3.1. ADMINISTRATION. The Plan shall be administered by the Board.
Subject to the provisions of the Plan, the Board shall be authorized to
interpret the Plan, to establish, amend and rescind any rules and regulations
relating to the Plan, and to make all other determinations necessary or
advisable for the administration of the Plan. The Board's interpretation of the
Plan, and all actions taken and determinations made by the Board pursuant to the
powers vested in it hereunder, shall be conclusive and binding upon all parties
concerned including the Company, its shareholders and persons granted awards
under the Plan. The Board may appoint a plan administrator to carry out the
ministerial functions of the Plan, but the administrator shall have no other
authority or powers of the Board.

         3.2. RELIANCE. In administering the Plan, the Board may rely upon any
information furnished by the Company, its public accountants and other experts.
No individual will have personal liability by reason of anything done or omitted
to be done by the Company or the Board in connection with the Plan. This
limitation of liability shall not be exclusive of any other limitation of
liability to which any such person may be entitled under the Company's
certificate of incorporation or otherwise.

                                    ARTICLE 4
                                     SHARES

         4.1. SOURCE OF SHARES FOR THE PLAN. The shares of Stock that may be
issued pursuant to the Plan shall be issued under the Equity Incentive Plan,
subject to all of the terms and conditions of the Equity Incentive Plan. The
terms contained in the Equity Incentive Plan are incorporated into and made a
part of this Plan with respect to Restricted Stock Units, Deferred Stock Units
and Options granted pursuant hereto and any such awards shall be governed by and
construed in accordance with the Equity Incentive Plan. In the event of any
actual or alleged conflict between the provisions of the Equity Incentive Plan
and the provisions of this Plan, the provisions of the Equity

                                      -3-
<PAGE>

Incentive Plan shall be controlling and determinative. This Plan does not
constitute a separate source of shares for the grant of the equity awards
described herein.

                                    ARTICLE 5
                                CASH COMPENSATION

         5.1. BASE ANNUAL CASH RETAINER. Each Eligible Participant shall be paid
a Base Annual Cash Retainer for service as a director during each Plan Year. The
amount of the Base Annual Cash Retainer shall be established from time to time
by the Board. Until changed by the Board, the Base Annual Cash Retainer for a
full Plan Year shall be $25,000. The Base Annual Cash Retainer shall be payable
in approximately equal quarterly installments in advance, beginning on the date
of the annual shareholders meeting; provided, however, that for the first Plan
Year, the first installment shall begin on the Effective Date and be prorated
based on the number of full months in such quarter after the Effective Date. For
example, if the Effective Date occurs on July 15, 2005, the quarterly
installment for the third quarter of 2005 will be $4,167 (2/3 times $6,250), and
the quarterly installment for the fourth quarter of 2005 will be $6,250. Any
cash retainers or other remuneration paid to Non-Employee Directors for service
prior to the Effective Date shall have been paid otherwise than under this Plan.

         Each person who first becomes an Eligible Participant on a date other
than the Effective Date or an annual meeting date shall be paid a retainer equal
to the quarterly installment of the Base Annual Cash Retainer for the first
quarter of eligibility, based on the number of full months he or she serves as a
Non-Employee Director during such quarter. Payment of such prorated Base Annual
Cash Retainer shall begin on the date that the person first becomes an Eligible
Participant.

         5.2. SUPPLEMENTAL ANNUAL CASH RETAINER. Certain Eligible Participants
shall be paid a Supplemental Annual Cash Retainer for service as chair of a
committee of the Board during a Plan Year, payable quarterly at the same times
as installments of the Base Annual Cash Retainer are paid. The amount of the
Supplemental Annual Cash Retainer shall be established from time to time by the
Board. Until changed by the Board, the Supplemental Annual Cash Retainer for a
full Plan Year shall be as follows:

<TABLE>
<S>                                                                                         <C>
Chair of Audit Committee                                                                    $7,500
Chair of Compensation Committee                                                             $5,000
Chair of Nominating & Corporate Governance Committee                                        $5,000
Chair of any Special Committee formed by the Nominating & Corporate Governance Committee    $5,000

</TABLE>

                                      -4-
<PAGE>

A prorata Supplemental Annual Cash Retainer will be paid to any Eligible
Participant who becomes the chair of a committee of the Board on a date other
than the beginning of a Plan Year, based on the number of full months he or she
serves as a chair of the applicable committee of the Board.

         5.3. MEETING FEES. Each Non-Employee Director shall be paid a meeting
fee for each meeting of the Board or committee thereof he or she attends. The
amount of the meeting fees shall be established from time to time by the Board.
Until changed by the Board, the meeting fee for attending a meeting of the Board
or any committee thereof shall be $1,500. Non-Employee Directors shall also be
paid a fee in the amount of $750 for participation in a telephonic meeting of
the Board or any committee thereof, provided that minutes are kept at such
telephonic meeting. For the avoidance of doubt, if a Non-Employee Director
attends a Board meeting and a committee meeting on a single day, he or she shall
receive a meeting fee for each meeting attended and at which minutes were kept.

         5.4.TRAVEL EXPENSE REIMBURSEMENT All Eligible Participants shall be
reimbursed for reasonable travel expenses (including spouse's expenses to attend
events to which spouses are invited) in connection with attendance at meetings
of the Board and its committees, or other Company functions at which the Chief
Executive Officer or Chair of the Board requests the Non-Employee Director to
participate. If the travel expense is related to the reimbursement of commercial
airfare, such reimbursement will cover first-class rates for domestic travel or
business-class rates for international travel. If the travel expense is related
to reimbursement of non-commercial air travel, such reimbursement shall not
exceed the rate for comparable travel by means of commercial airlines.

                                    ARTICLE 6
                               EQUITY COMPENSATION

         6.1. ANNUAL STOCK RETAINER

         (a) Grant of Restricted Stock Units. Each Eligible Participant shall
receive an award of Restricted Stock Units on the same dates that installments
of Base Annual Cash Retainers are paid. Such Restricted Stock Units shall be
subject to the terms and restrictions described below in this Article 6, and are
subject to share availability under the Equity Incentive Plan. The number of
Restricted Stock Units to be granted shall be established from time to time by
the Board. Until changed by the Board, the number of Restricted Stock Units to
be granted for a full quarter of service shall be determined by dividing $12,500
by the Fair Market Value of one share of Stock as of the grant date, and
rounding up to the nearest whole share.

         For the first Plan Year, the first grant of Restricted Stock Units
shall be made on the Effective Date and be prorated based on the number of full
months in such quarter

                                      -5-
<PAGE>

after the Effective Date. For example, if the Effective Date occurs on July 15,
2005, the grant of Restricted Stock Units for the third quarter of 2005 will be
determined by dividing $8,333 (2/3 times $12,500) by the Fair Market Value of
one share of Stock on the Effective Date and rounding up to the nearest whole
share. Each person who first becomes an Eligible Participant on a date other
than the Effective Date or an annual meeting date shall receive a prorata grant
of Restricted Stock Units, based on the number of full months he or she serves
as a Non-Employee Director during such quarter.

         (b) Vesting. Restricted Stock Units granted to an Eligible Participant
under the Plan shall be credited to a bookkeeping account on behalf of the
participant and shall vest and become non-forfeitable on the first annual
shareholders meeting next following the date of grant; provided, however, that
Restricted Stock Units shall become fully vested on the earlier occurrence of
(i) the termination of the grantee's service as a director of the Company due to
his or her death, Disability or termination without Cause, or (ii) a Change in
Control of the Company (as defined in the Equity Incentive Plan) if the
Restricted Stock Units are not assumed by the surviving company or equitably
converted or substituted in connection with such Change in Control (in any such
case, the "Vesting Date"). If the grantee's service as a director of the Company
(whether or not in a Non-Employee Director capacity) terminates other than as
described in clause (i) or (ii) of the foregoing sentence, then the grantee
shall forfeit all of his or her right, title and interest in and to any unvested
Restricted Stock Units as of the date of such termination from the Board and
such Restricted Stock Units shall be reconveyed to the Company without further
consideration or any act or action by the grantee.

         (c) Conversion to Deferred Stock Units. Restricted Stock Units that
vest in accordance with Section 6.1(b) above, shall be converted on the Vesting
Date to Deferred Stock Units, which in turn shall be converted to actual shares
of stock on the date that is six months after the participant ceases to serve as
a director of the Company in any capacity (the "Conversion Date"). Stock
certificates evidencing the conversion of Deferred Stock Units into shares of
Stock shall be registered on the books of the Company in the Non-Employee
Director's name as of the Conversion Date and delivered to the Non-Employee
Director as soon as practical thereafter.

         (d) Restrictions on Transfer. Restricted Stock Units are not assignable
or transferable. Deferred Stock Units are not assignable or transferable other
than by will or the laws of descent and distribution or pursuant to a qualified
domestic relations order. Neither Restricted Stock Units nor Deferred Stock
Units may be pledged, hypothecated or otherwise encumbered to or in favor of any
party other than the Company or an affiliate, or be subjected to any lien,
obligation or liability of grantee to any other party other than the Company or
an affiliate.

         (e) Rights as a Shareholder. A Non-Employee Director shall not have
voting or any other rights as a shareholder of the Company with respect to the
Restricted Stock Units or Deferred Stock Units. Upon conversion of the Deferred
Stock Units into shares

                                      -6-
<PAGE>

of Stock, the Non-Employee Director will obtain full voting and other rights as
a shareholder of the Company.

         (f) Dividend Equivalents. If and when dividends or distributions are
paid with respect to the Stock, Non-Employee Directors holding Restricted Stock
Units or Deferred Stock Units under this Plan shall be credited with additional
Restricted Stock Units or Deferred Stock Units equal to the dollar amount or
fair market value of such dividends or distributions paid with respect to that
number of shares of Stock represented by his or her Restricted Stock Units or
Deferred Stock Units immediately prior to such dividend or distribution. The
number of additional Restricted Stock Units or Deferred Stock Units to be so
credited shall be determined by dividing (i) the dollar amount or fair market
value of such dividends or distributions, by (ii) the Fair Market Value of a
share of Stock as of the payment date of such dividend or distribution. Any such
additional Restricted Stock Units or Deferred Stock Units so credited shall be
subject to the same forfeiture restrictions, restrictions on transferability,
and deferral terms as apply to the Restricted Stock Units or Deferred Stock
Units with respect to which they were granted.

         (g) Award Certificates. All awards of Restricted Stock Units and
Deferred Stock Units shall be evidenced by a written Award Certificate between
the Company and the Non-Employee Director, which shall include such provisions,
not inconsistent with the Plan or the Equity Incentive Plan, as may be specified
by the Board.

         6.2 STOCK OPTIONS

         (a) Initial Option Grant. Subject to share availability under the
Equity Incentive Plan, on the date that a new Non-Employee Director is initially
elected or appointed to the Board, such director will receive an Option to
purchase (i) 8,000 shares of Stock, if such date is more than six (6) months
before the next annual shareholders meeting, or (ii) 4,000 shares of Stock, if
such date is exactly or less than six (6) months before the next annual
shareholders meeting or on the date of an annual shareholders meeting (an
"Initial Option Grant"). Non-Employee Directors serving on the Board as of the
Effective Date shall not be eligible for an Initial Option Grant. Any other
Non-Employee Director shall be eligible to receive both an Initial Option Grant
and an Annual Option Grant (as defined below) in his or her initial year of
service.

         (b) Annual Option Grant. Subject to share availability under the Equity
Incentive Plan, on the day of the 2006 annual meeting of the Company's
shareholders, and on the day of each subsequent annual meeting of the Company's
shareholders, each Eligible Participant in service on that date shall receive an
Option to purchase 4,000 shares of Stock (the "Annual Option Grant"). For the
avoidance of doubt, each Eligible Participant shall receive the Option to
purchase 4,000 shares of Stock under this paragraph 6.2(b) even in the event
that such Eligible Participant earlier received or simultaneously receives the
Option to purchase 4,000 shares of Stock as specified in paragraph 6.2(a)(ii).

                                      -7-
<PAGE>

         (c) Terms and Conditions of Options. Options granted under this Section
6.2 shall be evidenced by a written Award Certificate, and shall be subject to
the terms and conditions described below and of the Equity Incentive Plan.

                  (i) Exercise Price. The exercise price per share under an
         Option shall be the Fair Market Value on the date of grant of the
         Option.

                  (ii) Option Term. Subject to earlier termination as provided
         herein, the Option shall expire on the tenth anniversary of the date of
         grant.

                  (iii) Vesting. Each Option granted pursuant to an Initial
         Option Grant shall, unless earlier terminated as provided in Section
         6.2(d), vest and become exercisable as to one-third (1/3) of the shares
         on each of the first three (3) anniversaries of the date of grant. Each
         Option granted pursuant to an Annual Option Grant shall, unless earlier
         terminated as provided in Section 6.2(d), vest and become exercisable
         in full at the first annual meeting of the Company's shareholders after
         the grant date. Notwithstanding the foregoing, all Options granted
         under Section 6.2 shall become fully vested and exercisable on the
         earlier occurrence of (i) the termination of the optionee's service as
         a director of the Company due to his or her death, Disability or
         termination without Cause, or (ii) a Change in Control of the Company
         (as defined in the Equity Incentive Plan) if the Options are not
         assumed by the surviving company or equitably converted or substituted
         in connection with such Change in Control (in any such case, the
         "Vesting Date"). If the optionee's service as a director of the Company
         (whether or not in a Non-Employee Director capacity) terminates other
         than as described in clause (i) or (ii) of the foregoing sentence, then
         the optionee shall forfeit all of his or her right, title and interest
         in and to any unvested Options as of the date of such termination from
         the Board.

         (d) Restrictions on Transfer. Options granted under Section 6.2 are not
assignable or transferable other than by will or the laws of descent and
distribution or pursuant to a qualified domestic relations order, and may not be
pledged, hypothecated or otherwise encumbered to or in favor of any party other
than the Company or an affiliate, or be subjected to any lien, obligation or
liability of grantee to any other party other than the Company or an affiliate.
Such Options may be exercised, during the lifetime of the Non-Employee Director,
only by the Non-Employee Director.

                                    ARTICLE 7
                     AMENDMENT, MODIFICATION AND TERMINATION

         7.1. AMENDMENT, MODIFICATION AND TERMINATION. The Board may, at any
time and from time to time, amend, modify or terminate the Plan without
shareholder approval; provided, however, that if an amendment to the Plan would,
in the

                                      -8-
<PAGE>

reasonable opinion of the Board, require shareholder approval under applicable
laws, policies or regulations or the applicable listing or other requirements of
a securities exchange on which the Stock is listed or traded, then such
amendment shall be subject to shareholder approval; and provided further, that
the Board may condition any other amendment or modification on the approval of
shareholders of the Company for any reason.

                                    ARTICLE 8
                               GENERAL PROVISIONS

         8.1. ADJUSTMENTS. The adjustment provisions of the Equity Incentive
Plan shall apply with respect to awards of Restricted Stock Units, Deferred
Stock Units and Options outstanding or to be granted pursuant to this Plan.

         8.2. DURATION OF THE PLAN. The Plan shall remain in effect until
terminated by the Board.

         8.3. EXPENSES OF THE PLAN. The expenses of administering the Plan shall
be borne by the Company.

         8.4. STATUS OF THE PLAN. The provisions of Articles 6 of the Plan are
intended to be a nonqualified, unfunded plan of deferred compensation under the
Code. Plan benefits shall be paid from the general assets of the Company or as
otherwise directed by the Company. A participant shall have the status of a
general unsecured creditor of the Company with respect to his or her right to
receive Stock or other payment upon exercise of the Options or settlement of the
Deferred Stock Units granted under the Plan. No right or interest in the
Options, Restricted Stock Units or Deferred Stock Units shall be subject to the
claims of creditors of the Non-Employee Director or to liability for the debts,
contracts or engagements of the Non-Employee Director. To the extent that any
participant acquires the right to receive payments under the Plan (from whatever
source), such right shall be no greater than that of an unsecured general
creditor of the Company. Participants and their beneficiaries shall not have any
preference or security interest in the assets of the Company other than as a
general unsecured creditor.

         8.6. EFFECTIVE DATE. The Plan was originally adopted by the Board on
April 25, 2005, and will become effective on the Effective Date.

                                    ADAMS RESPIRATORY THERAPEUTICS, INC.

                                    By: /s/ David P. Becker
                                        ________________________________

                                       -9-<PAGE>
                                                                    Exhibit 10.9

                           NON-STATUTORY STOCK OPTION
                           for Non-Employee Directors

                                Non-transferable

                             INITIAL OPTION GRANT TO

                          -----------------------------
                                (the "Optionee")

 the right to purchase from Adams Respiratory Therapeutics, Inc. (the "Company")

                                   -----------

  shares of its common stock, $0.01 par value, at the price of $_____ per share

pursuant to and subject to the provisions of the Adams Respiratory Therapeutics,
Inc. Director Compensation Plan (the "Director Compensation Plan"), which is
operated as a subplan of the Adams Respiratory Therapeutics, Inc. 2005 Incentive
Plan (the "Equity Incentive Plan" and, together with the Director Compensation
Plan, the "Plans"), and to the terms and conditions set forth on the following
page.

Unless vesting is accelerated in accordance with the Plans, the Options shall
vest (become exercisable) in accordance with the following schedule:

<TABLE>
<CAPTION>
          Anniversary of Grant Date        Percent of Option Shares Vested
          -------------------------        -------------------------------
<S>                                        <C>
                     1st                                 33%
                     2nd                                 66%
                     3rd                                100%
</TABLE>

     IN WITNESS WHEREOF, Adams Respiratory Therapeutics, Inc., acting by and
through its duly authorized officers, has caused this Certificate to be executed
as of the Grant Date.

                                        ADAMS RESPIRATORY THERAPEUTICS, INC.

                                        By: ____________________________________
                                        Its: Authorized Officer

                                        Grant Date: _______________

                                        Accepted by Optionee: __________________
<PAGE>
TERMS AND CONDITIONS

     1. Grant of Option. Adams Respiratory Therapeutics, Inc. (the "Company")
hereby grants to the Optionee named on Page 1 hereof ("Optionee"), subject to
the restrictions and the terms and conditions set forth in the Plans and in this
award certificate (the "Certificate"), stock options to purchase from the
Company (the "Options"), the number of shares indicated on Page 1 of the
Company's $0.01 par value common stock, at the exercise price per share set
forth on Page 1. Capitalized terms used herein and not otherwise defined shall
have the meanings assigned to such terms in the Plans.

     2. Vesting of Options. The Options shall vest (become exercisable) in
accordance with the schedule shown on Page 1 of this Certificate.
Notwithstanding the foregoing vesting schedule, all Options shall become fully
vested and exercisable upon (i) the termination of Optionee's service as a
director of the Company due to death, Disability, or termination without Cause,
or (ii) a Change in Control of the Company, if the Options are not assumed by
the surviving company or equitably converted or substituted.

     3. Term of Options and Limitations on Right to Exercise. The term of the
Options will be for a period of ten years, expiring at 5:00 p.m., Eastern Time,
on the tenth anniversary of the Grant Date (the "Expiration Date"). To the
extent not previously exercised, the Options will lapse prior to the Expiration
Date upon the earliest to occur of the following circumstances:

     (a)Thirty-six months after the termination of Optionee's service as a
director of the Company for any reason other than for Cause;

     (b) 5:00 p.m., Eastern Time, on the date of the termination of Optionee's
service as a director of the Company if such termination is for Cause.

     Upon Optionee's death, the Options may be exercised by Optionee's
beneficiary designated pursuant to the Plans. If Optionee or his or her
beneficiary exercises an Option after termination of service, the Options may be
exercised only with respect to the Shares that were otherwise vested on
Optionee's termination of service.

     4. Exercise of Option. The Options shall be exercised by (a) written notice
directed to the Secretary of the Company or his or her designee at the address
and in the form specified by the Secretary from time to time and (b) payment to
the Company in full for the Shares subject to such exercise (unless the exercise
is a broker-assisted cashless exercise, as described below). If the person
exercising an Option is not Optionee, such person shall also deliver with the
notice of exercise appropriate proof of his or her right to exercise the Option.
Payment for such Shares shall be in (a) cash, (b) Shares previously acquired by
the purchaser, which have been held by the purchaser for such period of time, if
any, as necessary to avoid the recognition of an expense under generally
accepted accounting principles as a result of the exercise of the Options, or
(c) any combination thereof, for the number of Shares specified in such written
notice. The value of surrendered Shares for this purpose shall be the Fair
Market Value on the exercise date. To the extent permitted under Regulation T of
the Federal Reserve Board, and subject to applicable securities laws and any
limitations as may be applied from time to time by the Committee (which need not
be uniform), the Options may be exercised through a broker in a so-called
"cashless exercise" whereby the broker sells the Option Shares on behalf of
Optionee and delivers cash sales proceeds to the Company in payment of the
exercise price. In such case, the date of exercise shall be deemed to be the
date on which notice of exercise is received by the Company and the exercise
price shall be delivered to the Company by the settlement date.

     5. Beneficiary Designation. Optionee may, in the manner determined by the
Committee, designate a beneficiary to exercise the rights of Optionee hereunder
and to receive any distribution with respect to the Options upon Optionee's
death. A beneficiary, legal guardian, legal representative, or other person
claiming any rights hereunder is subject to all terms and conditions of this
Certificate and the Plans, and to any additional restrictions deemed necessary
or appropriate by the Committee. If no beneficiary has been designated or
survives Optionee, the Options may be exercised by the legal representative of
Optionee's estate, and payment shall be made to Optionee's estate. Subject to
the foregoing, a beneficiary designation may be changed or revoked by Optionee
at any time provided the change or revocation is filed with the Company.

     6. Limitation of Rights. The Options do not confer to Optionee or
Optionee's beneficiary designated pursuant to Paragraph 5 any rights of a
shareholder of the Company unless and until Shares are in fact issued to such
person in connection with the exercise of the Options. Nothing in this
Certificate shall interfere with or limit in any way the right of the Company to
terminate Optionee's service as a director at any time, nor confer upon Optionee
any right to continue service as a director of the Company.

     7. Stock Reserve. The Company shall at all times during the term of this
Certificate reserve and keep available such number of Shares as will be
sufficient to satisfy the requirements of this Certificate.

     8. Restrictions on Transfer and Pledge. No right or interest of Optionee in
the Options may be pledged, encumbered, or hypothecated to or in favor of any
party other than the Company or an Affiliate, or shall be subject to any lien,
obligation, or liability of Optionee to any other party other than the Company
or an Affiliate. The Options are not assignable or transferable by Optionee
other than by will or the laws of descent and distribution or pursuant to a
domestic relations order that would satisfy Section 414(p)(1)(A) of the Code if
such Section applied to an Option under the Plans. The Options may be exercised
during the lifetime of Optionee only by Optionee.

     9. Restrictions on Issuance of Shares. If at any time the Committee shall
determine in its discretion, that registration, listing or qualification of the
Shares covered by the Options upon any Exchange or under any foreign, federal,
or local law or practice, or the consent or approval of any governmental
regulatory body, is necessary or desirable as a condition to the exercise of the
Options, the Options may not be exercised in whole or in part unless and until
such registration, listing, qualification, consent or approval shall have been
effected or obtained free of any conditions not acceptable to the Committee.

     10. Plans Control. The terms contained in the Plans are incorporated into
and made a part of this Certificate and this Certificate shall be governed by
and construed in accordance with the Plans. In the event of any actual or
alleged conflict between the provisions of the Plans and the provisions of this
Certificate, the provisions of the Plans shall be controlling and determinative.
In the event of any actual or alleged conflict between the provisions of the two
Plans, the provisions of the Equity Incentive Plan shall be controlling and
determinative.

     11. Successors. This Certificate shall be binding upon any successor of the
Company, in accordance with the terms of this Certificate and the Plans.

     12. Severability. If any one or more of the provisions contained in this
Certificate is invalid, illegal or unenforceable, the other provisions of this
Certificate will be construed and enforced as if the invalid, illegal or
unenforceable provision had never been included.

     13. Notice. Notices and communications under this Certificate must be in
writing and either personally delivered or sent by registered or certified
United States mail, return receipt requested, postage prepaid. Notices to the
Company must be addressed to Adams Respiratory Therapeutics, Inc., 425 Main
Street, Chester, New Jersey 07930, Attn: Secretary, or any other address
designated by the Company in a written notice to Grantee. Notices to Grantee
will be directed to the address of Grantee then currently on file with the
Company, or at any other address given by Grantee in a written notice to the
Company.
<PAGE>
                           NON-STATUTORY STOCK OPTION
                           for Non-Employee Directors

                                Non-transferable

                             ANNUAL OPTION GRANT TO

                          -----------------------------
                                (the "Optionee")

 the right to purchase from Adams Respiratory Therapeutics, Inc. (the "Company")

                                      4,000

  shares of its common stock, $0.01 par value, at the price of $_____ per share

pursuant to and subject to the provisions of the Adams Respiratory Therapeutics,
Inc. Director Compensation Plan (the "Director Compensation Plan"), which is
operated as a subplan of the Adams Respiratory Therapeutics, Inc. 2005 Incentive
Plan (the "Equity Incentive Plan" and, together with the Director Compensation
Plan, the "Plans"), and to the terms and conditions set forth on the following
page.

Unless vesting is accelerated in accordance with the Plans, the Options shall
vest (become exercisable) at the first annual meeting of the Company's
shareholders after the Grant Date.

     IN WITNESS WHEREOF, Adams Respiratory Therapeutics, Inc., acting by and
through its duly authorized officers, has caused this Certificate to be executed
as of the Grant Date.

                                        ADAMS RESPIRATORY THERAPEUTICS, INC.

                                        By: ____________________________________
                                        Its: Authorized Officer

                                        Grant Date: _______________

                                        Accepted by Optionee: __________________
<PAGE>
TERMS AND CONDITIONS

     1. Grant of Option. Adams Respiratory Therapeutics, Inc. (the "Company")
hereby grants to the Optionee named on Page 1 hereof ("Optionee"), subject to
the restrictions and the terms and conditions set forth in the Plans and in this
award certificate (the "Certificate"), stock options to purchase from the
Company (the "Options"), the number of shares indicated on Page 1 of the
Company's $0.01 par value common stock, at the exercise price per share set
forth on Page 1. Capitalized terms used herein and not otherwise defined shall
have the meanings assigned to such terms in the Plans.

     2. Vesting of Options. The Options shall vest (become exercisable) in
accordance with the schedule shown on Page 1 of this Certificate.
Notwithstanding the foregoing vesting schedule, all Options shall become fully
vested and exercisable upon (i) the termination of Optionee's service as a
director of the Company due to death, Disability, or termination without Cause,
or (ii) a Change in Control of the Company, if the Options are not assumed by
the surviving company or equitably converted or substituted.

     3. Term of Options and Limitations on Right to Exercise. The term of the
Options will be for a period of ten years, expiring at 5:00 p.m., Eastern Time,
on the tenth anniversary of the Grant Date (the "Expiration Date"). To the
extent not previously exercised, the Options will lapse prior to the Expiration
Date upon the earliest to occur of the following circumstances:

     (a)Thirty-six months after the termination of Optionee's service as a
director of the Company for any reason other than for Cause;

     (b) 5:00 p.m., Eastern Time, on the date of the termination of Optionee's
service as a director of the Company if such termination is for Cause.

     Upon Optionee's death, the Options may be exercised by Optionee's
beneficiary designated pursuant to the Plans. If Optionee or his or her
beneficiary exercises an Option after termination of service, the Options may be
exercised only with respect to the Shares that were otherwise vested on
Optionee's termination of service.

     4. Exercise of Option. The Options shall be exercised by (a) written notice
directed to the Secretary of the Company or his or her designee at the address
and in the form specified by the Secretary from time to time and (b) payment to
the Company in full for the Shares subject to such exercise (unless the exercise
is a broker-assisted cashless exercise, as described below). If the person
exercising an Option is not Optionee, such person shall also deliver with the
notice of exercise appropriate proof of his or her right to exercise the Option.
Payment for such Shares shall be in (a) cash, (b) Shares previously acquired by
the purchaser, which have been held by the purchaser for such period of time, if
any, as necessary to avoid the recognition of an expense under generally
accepted accounting principles as a result of the exercise of the Options, or
(c) any combination thereof, for the number of Shares specified in such written
notice. The value of surrendered Shares for this purpose shall be the Fair
Market Value on the exercise date. To the extent permitted under Regulation T of
the Federal Reserve Board, and subject to applicable securities laws and any
limitations as may be applied from time to time by the Committee (which need not
be uniform), the Options may be exercised through a broker in a so-called
"cashless exercise" whereby the broker sells the Option Shares on behalf of
Optionee and delivers cash sales proceeds to the Company in payment of the
exercise price. In such case, the date of exercise shall be deemed to be the
date on which notice of exercise is received by the Company and the exercise
price shall be delivered to the Company by the settlement date.

     5. Beneficiary Designation. Optionee may, in the manner determined by the
Committee, designate a beneficiary to exercise the rights of Optionee hereunder
and to receive any distribution with respect to the Options upon Optionee's
death. A beneficiary, legal guardian, legal representative, or other person
claiming any rights hereunder is subject to all terms and conditions of this
Certificate and the Plans, and to any additional restrictions deemed necessary
or appropriate by the Committee. If no beneficiary has been designated or
survives Optionee, the Options may be exercised by the legal representative of
Optionee's estate, and payment shall be made to Optionee's estate. Subject to
the foregoing, a beneficiary designation may be changed or revoked by Optionee
at any time provided the change or revocation is filed with the Company.

     6. Limitation of Rights. The Options do not confer to Optionee or
Optionee's beneficiary designated pursuant to Paragraph 5 any rights of a
shareholder of the Company unless and until Shares are in fact issued to such
person in connection with the exercise of the Options. Nothing in this
Certificate shall interfere with or limit in any way the right of the Company to
terminate Optionee's service as a director at any time, nor confer upon Optionee
any right to continue service as a director of the Company.

     7. Stock Reserve. The Company shall at all times during the term of this
Certificate reserve and keep available such number of Shares as will be
sufficient to satisfy the requirements of this Certificate.

     8. Restrictions on Transfer and Pledge. No right or interest of Optionee in
the Options may be pledged, encumbered, or hypothecated to or in favor of any
party other than the Company or an Affiliate, or shall be subject to any lien,
obligation, or liability of Optionee to any other party other than the Company
or an Affiliate. The Options are not assignable or transferable by Optionee
other than by will or the laws of descent and distribution or pursuant to a
domestic relations order that would satisfy Section 414(p)(1)(A) of the Code if
such Section applied to an Option under the Plans. The Options may be exercised
during the lifetime of Optionee only by Optionee.

     9. Restrictions on Issuance of Shares. If at any time the Committee shall
determine in its discretion, that registration, listing or qualification of the
Shares covered by the Options upon any Exchange or under any foreign, federal,
or local law or practice, or the consent or approval of any governmental
regulatory body, is necessary or desirable as a condition to the exercise of the
Options, the Options may not be exercised in whole or in part unless and until
such registration, listing, qualification, consent or approval shall have been
effected or obtained free of any conditions not acceptable to the Committee.

     10. Plans Control. The terms contained in the Plans are incorporated into
and made a part of this Certificate and this Certificate shall be governed by
and construed in accordance with the Plans. In the event of any actual or
alleged conflict between the provisions of the Plans and the provisions of this
Certificate, the provisions of the Plans shall be controlling and determinative.
In the event of any actual or alleged conflict between the provisions of the two
Plans, the provisions of the Equity Incentive Plan shall be controlling and
determinative.

     11. Successors. This Certificate shall be binding upon any successor of the
Company, in accordance with the terms of this Certificate and the Plans.

     12. Severability. If any one or more of the provisions contained in this
Certificate is invalid, illegal or unenforceable, the other provisions of this
Certificate will be construed and enforced as if the invalid, illegal or
unenforceable provision had never been included.

     13. Notice. Notices and communications under this Certificate must be in
writing and either personally delivered or sent by registered or certified
United States mail, return receipt requested, postage prepaid. Notices to the
Company must be addressed to Adams Respiratory Therapeutics, Inc., 425 Main
Street, Chester, New Jersey 07930, Attn: Secretary, or any other address
designated by the Company in a written notice to Grantee. Notices to Grantee
will be directed to the address of Grantee then currently on file with the
Company, or at any other address given by Grantee in a written notice to the
Company.
<PAGE>
                     RESTRICTED STOCK UNIT AWARD CERTIFICATE

                           for Non-Employee Directors

                                Non-transferable

                                    GRANT TO

                          -----------------------------
                                   ("Grantee")

           by Adams Respiratory Therapeutics, Inc. (the "Company") of

                                   [_________]

     restricted stock units convertible into shares of its common stock, par
value $0.01 (the "Restricted Stock Units")

pursuant to and subject to the provisions of the Adams Respiratory Therapeutics,
Inc. Director Compensation Plan (the "Director Compensation Plan"), which is
operated as a subplan of the Adams Respiratory Therapeutics, Inc. 2005 Incentive
Plan (the "Equity Incentive Plan" and, together with the Director Compensation
Plan, the "Plans"), and to the terms and conditions set forth on the following
page.

Unless vesting is accelerated in accordance with the Plans, the Restricted Stock
Units shall vest (become non-forfeitable) on the first annual shareholders
meeting next following the Grant Date.

IN WITNESS WHEREOF, Adams Respiratory Therapeutics, Inc. has caused this
Certificate to be executed as of the Grant Date, as indicated below.

                                        ADAMS RESPIRATORY THERAPEUTICS, INC.

                                        By: ____________________________________
                                        Its: Authorized Officer

                                        Grant Date: _______________

                                        Accepted by Optionee: __________________
<PAGE>
TERMS AND CONDITIONS

     1. Grant of Restricted Stock Units. The Adams Respiratory Therapeutics,
Inc. (the "Company") hereby grants to the Grantee named on page 1 hereof,
subject to the restrictions and the terms and conditions set forth in the Plans
and in this award certificate (this "Certificate"), the number of restricted
stock units indicated on page 1 hereof (the "Restricted Stock Units") which
represent the right to receive an equal number of Shares of the Company's Stock
on the terms set forth in this Certificate. Capitalized terms used herein and
not otherwise defined shall have the meanings assigned to such terms in the
Plans.

     2. Vesting of Restricted Stock Units. The Restricted Stock Units have been
credited to a bookkeeping account on behalf of Grantee. The Restricted Stock
Units will vest and become non-forfeitable on the earliest to occur of the
following (the "Vesting Date"):

     (a) the first annual shareholders meeting next following the Grant Date; or

     (b) the termination of Grantee's service as a director of the Company due
to death, Disability, or termination without Cause; or

     (c) a Change in Control of the Company, if the Restricted Stock Units are
not assumed by the surviving company or equitably converted or substituted.

If Grantee's service as a director terminates prior to the Vesting Date for any
reason other than as described in (b) or (c) above, Grantee shall forfeit all
right, title and interest in and to the Restricted Stock Units as of the date of
such termination and the Restricted Stock Units will be reconveyed to the
Company without further consideration or any act or action by Grantee. Any
reference herein to Grantee's termination of service shall be interpreted to
mean Grantee's "separation from service" as defined in Code Section 409A and
Treasury regulations and guidance with respect to such law.

     3. Conversion to Stock. Unless the Restricted Stock Units are forfeited
prior to the Vesting Date as provided in Paragraph 2 above, the Restricted Stock
Units will be converted on the Vesting Date to Deferred Stock Units, which in
turn shall be converted to actual Shares of Stock on the date that is six (6)
months after the date the Grantee ceases to serve as a director of the Company
in any capacity (the "Conversion Date"). Stock certificates evidencing the
conversion of the Deferred Stock Units into shares of Stock shall be registered
on the books of the Company in the Grantee's name as of the Conversion Date and
delivered to the Grantee as soon as practical thereafter.

     4. Dividend Equivalents. If and when dividends or other distributions are
paid with respect to the Stock while the Restricted Stock Units or Deferred
Stock Units are outstanding, the dollar amount or fair market value of such
dividends or distributions with respect to the number of shares of Stock then
underlying the Restricted Stock Units or Deferred Stock Units shall be converted
into additional Restricted Stock Units or Deferred Stock Units in Grantee's
name, based on the Fair Market Value of the Stock as of the date such dividends
or distributions were payable, and such additional Restricted Stock Units or
Deferred Stock Units shall be subject to the same transfer restrictions as apply
to the Restricted Stock Units or Deferred Stock Units with respect to which they
relate. Upon conversion of the Deferred Stock Units into shares of Stock at the
Conversion Date or any applicable deferral termination date, Grantee will obtain
full voting and other rights as a shareholder of the Company.

     5. Changes in Capital Structure. The provisions of Article 15 of the Equity
Incentive Plan shall apply to this award and are incorporated herein by
reference. Without limiting the foregoing, in the event the Stock shall be
changed into or exchanged for a different number or class of shares of stock or
securities of the Company or of another company, whether through reorganization,
recapitalization, statutory share exchange, reclassification, stock split-up,
combination of shares, merger or consolidation, or otherwise, there shall be
substituted for each share of Stock then underlying a Restricted Stock Unit or
Deferred Stock Unit subject to this Certificate the number and class of shares
into which each outstanding share of Stock shall be so exchanged.

     6. Restrictions on Transfer and Pledge. Restricted Stock Units are not
assignable or transferable. Deferred Stock Units are not assignable or
transferable other than by will or the laws of descent and distribution or
pursuant to a qualified domestic relations order. Neither Restricted Stock Units
nor Deferred Stock Units may be pledged, hypothecated or otherwise encumbered to
or in favor of any party other than the Company or an Affiliate, or be subjected
to any lien, obligation or liability of grantee to any other party other than
the Company or an Affiliate.

     7. Limitation of Rights. Neither the Restricted Stock Units nor the
Deferred Stock Units confer to Grantee or Grantee's beneficiary any rights of a
shareholder of the Company unless and until shares of Stock are in fact issued
to such person in connection with the Restricted Stock Units and the Deferred
Stock Units. Nothing in this Certificate shall interfere with or limit in any
way the right of the Company to terminate Grantee's service as a director at any
time, nor confer upon Grantee any right to continue as a director of the
Company.

     8. Amendment. The Committee may amend, modify or terminate this Certificate
without approval of Grantee; provided, however, that such amendment,
modification or termination shall not, without Grantee's consent, reduce or
diminish the value of this Award. Notwithstanding anything herein to the
contrary, the Committee may, without Grantee's consent, amend or interpret this
Certificate to the extent necessary to comply with Section 409A of the Code and
Treasury regulations and guidance with respect to such law.

     9. Plans Control. The terms contained in the Plans are incorporated into
and made a part of this Certificate and this Certificate shall be governed by
and construed in accordance with the Plans. In the event of any actual or
alleged conflict between the provisions of the Plans and the provisions of this
Certificate, the provisions of the Plans shall be controlling and determinative.
In the event of any actual or alleged conflict between the provisions of the two
Plans, the provisions of the Equity Incentive Plan shall be controlling and
determinative.

     10. Successors. This Certificate shall be binding upon any successor of the
Company, in accordance with the terms of this Certificate and the Plans.

     11. Severability. If any one or more of the provisions contained in this
Certificate is deemed to be invalid, illegal or unenforceable, the other
provisions of this Certificate will be construed and enforced as if the invalid,
illegal or unenforceable provision had never been included.

     12. Notice. Notices and communications under this Certificate must be in
writing and either personally delivered or sent by registered or certified
United States mail, return receipt requested, postage prepaid. Notices to the
Company must be addressed to Adams Respiratory Therapeutics, Inc., 425 Main
Street, Chester, New Jersey 07930, Attn: Secretary, or any other address
designated by the Company in a written notice to Grantee. Notices to Grantee
will be directed to the address of Grantee then currently on file with the
Company, or at any other address given by Grantee in a written notice to the
Company.

                                      -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]